WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeStocks › TEVA

Which hedge funds own TEVA? TEVA PHARMACEUTICAL INDS LTD, Q2 2026 13F holders

Healthcare · Open on the interactive board

16 of the hedge funds tracked by WhaleCreep disclosed a position in TEVA (TEVA PHARMACEUTICAL INDS LTD) in their Q2 2026 13F filings, worth $3.6bn in total. The largest holder by portfolio weight is Rubric Capital Management at 4.8% of its book. 2 managers opened a new position this quarter: Brevan Howard Capital Management, Citadel Advisors.

16tracked managers holding
2opened this quarter
0exited this quarter

Which hedge funds hold TEVA? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Rubric Capital ManagementQ2 2026 4.8%$527.7m15,575,000 2% added
WCM Investment ManagementQ2 2026 3.6%$2.6bn41,315,232 1% added
Glenview Capital ManagementQ2 2026 3.4%$172.1m5,081,091 -24% reduced
Avidity PartnersQ2 2026 1.1%$6.8m200,000 -56% reduced
Duquesne Family Office LLCQ2 2026 0.5%$21.2m624,999 -74% reduced
Bridgewater AssociatesQ2 2026 0.2%$44.9m1,326,678 18% added
Woodline PartnersQ2 2026 0.1%$40.3m1,189,584 2% added
Millennium ManagementQ2 2026 0.1%$110.6m3,265,321 72% added
Tudor InvestmentQ2 2026 0.1%$16.6m490,000 -10% reduced
Point72 Asset Management LPQ2 2026 0.1%$35.9m1,059,778 -6% reduced
Holocene AdvisorsQ2 2026 0.0%$5.7m166,867 -8% reduced
Farallon Capital ManagementQ2 2026 0.0%$1.4m40,000 -89% reduced
Brevan Howard Capital ManagementQ2 2026 0.0%$338.5k10,200 new
D. E. Shaw & CoQ2 2026 0.0%$6.1m180,647 29% added
First ManhattanQ2 2026 0.0%$1.0m30,035 -31% reduced
Citadel AdvisorsQ2 2026 0.0%$2.5m73,304 new

Held in a manager's last filing on record

These managers have not filed for the latest quarter; their last disclosure is dated.

ManagerLast filingWeight
Greenlight CapitalQ4 20230.1%

How has hedge fund ownership of TEVA changed?

QuarterManagers holdingCombined value
Q2 202616$3.6bn
Q1 202614$3.2bn
Q4 202512$1.9bn
Q3 202515$1.5bn
Q2 202512$1.4bn
Q1 202512$1.2bn
Q4 202413$1.2bn
Q3 202416$840.1m
Q2 202414$721.1m
Q1 202412$581.1m
Q4 202314$427.3m
Q3 202312$401.8m
Q2 202310$265.3m
Q1 202310$216.0m
Q4 20228$247.9m
Q3 20228$315.9m

Counts every tracked manager that disclosed TEVA in that quarter's filing, including managers that have since stopped filing.